These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8141084)
21. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial. White HD Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893 [TBL] [Abstract][Full Text] [Related]
22. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Simoons ML; Maggioni AP; Knatterud G; Leimberger JD; de Jaegere P; van Domburg R; Boersma E; Franzosi MG; Califf R; Schröder R Lancet; 1993 Dec 18-25; 342(8886-8887):1523-8. PubMed ID: 7902905 [TBL] [Abstract][Full Text] [Related]
23. Is there an age limit for thrombolytic therapy? Sleight P Am J Cardiol; 1993 Dec; 72(19):30G-33G. PubMed ID: 8279358 [TBL] [Abstract][Full Text] [Related]
24. Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction. Al Khuwaitir TS; Wani BA; Dawood HA; Khan MA Saudi Med J; 2005 Jan; 26(1):130-2. PubMed ID: 15756370 [TBL] [Abstract][Full Text] [Related]
25. Intracranial hemorrhage complicating acute myocardial infarction in the era of thrombolytic therapy. Conrad AR; Feffer SE; Rajan RT; Freeman I South Med J; 1997 Jan; 90(1):5-12. PubMed ID: 9003815 [TBL] [Abstract][Full Text] [Related]
26. The need for wider utilization of thrombolytic therapy. Hennekens C Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III26-31. PubMed ID: 9422860 [TBL] [Abstract][Full Text] [Related]
29. Thrombolytic therapy: a review of its use in acute myocardial infarction. Bizjak ED; Mauro VF Ann Pharmacother; 1998; 32(7-8):769-84. PubMed ID: 9681094 [TBL] [Abstract][Full Text] [Related]
30. Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction. Schröder K; Wegscheider K; Neuhaus KL; Tebbe U; Schröder R Heart; 1997 Jun; 77(6):506-11. PubMed ID: 9227292 [TBL] [Abstract][Full Text] [Related]
31. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601 [TBL] [Abstract][Full Text] [Related]
37. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
38. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study). Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579 [TBL] [Abstract][Full Text] [Related]
39. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819 [TBL] [Abstract][Full Text] [Related]
40. Refining the risk-benefit equation for thrombolysis: how to identify the low risk patient before administering thrombolytic therapy. Nidorf M; Parsons R; Thompson P; Jamrozik K; Hobbs M Aust N Z J Med; 1998 Aug; 28(4):525-8. PubMed ID: 9777133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]